Today Synovus Financial Corp. (NYSE: SNV) is trading 3.31% higher.

The latest price, as of 12:09:57 est, was $40.34. Synovus has risen $1.29 over the previous day’s close.

284,376 shares have traded hands.

As of the previous close, Synovus has a YTD change of 17.99%. The company is set to release earnings on 2022-07-19.

For technical charts, analysis, and more on Synovus visit the company profile.

About Synovus Financial Corp.

Synovus Financial Corp. is a financial services company based in Columbus, Georgia, with approximately $53 billion in assets. Synovus provides commercial and retail banking, investment, and mortgage services through 289 branches in Georgia, Alabama, South Carolina, Florida, and Tennessee. Synovus Bank, a wholly owned subsidiary of Synovus, has been recognized as one of the country's 'Most Reputable Banks' by American Banker and the Reputation Institute.

To get more information on Synovus Financial Corp. and to follow the company's latest updates, you can visit the company's profile page here: Synovus Financial Corp.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold

The Best Laid Plans of Mice and Men — Part I

Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users

Squarespace Beats Revenue Estimates With Record Q1

BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million

How To Trade in a Bearish Market

AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement